Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-11-9
pubmed:abstractText
Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin inhibitor, that do not require monitoring or dose adjustment offer potential for prophylaxis against venous thromboembolism (VTE) after total knee replacement surgery.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1538-7933
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2178-85
pubmed:meshHeading
pubmed-meshheading:17764540-Acute Coronary Syndrome, pubmed-meshheading:17764540-Aged, pubmed-meshheading:17764540-Anticoagulants, pubmed-meshheading:17764540-Arthroplasty, Replacement, Knee, pubmed-meshheading:17764540-Benzimidazoles, pubmed-meshheading:17764540-Clinical Enzyme Tests, pubmed-meshheading:17764540-Double-Blind Method, pubmed-meshheading:17764540-Drug Administration Routes, pubmed-meshheading:17764540-Enoxaparin, pubmed-meshheading:17764540-Follow-Up Studies, pubmed-meshheading:17764540-Hemorrhage, pubmed-meshheading:17764540-Humans, pubmed-meshheading:17764540-Middle Aged, pubmed-meshheading:17764540-Postoperative Complications, pubmed-meshheading:17764540-Prodrugs, pubmed-meshheading:17764540-Pyridines, pubmed-meshheading:17764540-Treatment Outcome, pubmed-meshheading:17764540-Venous Thrombosis
pubmed:year
2007
pubmed:articleTitle
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
pubmed:affiliation
Sahlgrenska University Hospital/Ostra, Gothenburg, Sweden. b.eriksson@orthop.gu.se
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study